Skip to content

Impact of Digital Therapeutic on Metabolic Parameters

Impact of Digital Therapeutic Intervention on Metabolic Parameters in Obese Adults With Insulin Resistance, Prediabetes and Type 2 Diabetes as Compared to Conventional Intensive Obesity Management Programme

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04573296
Enrollment
100
Registered
2020-10-05
Start date
2020-02-26
Completion date
2022-11-30
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Insulin Resistance, Obesity, Prediabetic State

Brief summary

The purpose of this prospective randomized controlled study is to evaluate the impact of a six-month digitally administered behavioral change program on body weight, glycemic control and other metabolic parameters in obese adults with insulin resistance, prediabetes or type 2 diabetes as compared to conventional high-intensity lifestyle intervention program administered at a specialized department of a university hospital.

Detailed description

In this prospective randomized clinical study, obese adults with insulin resistance, prediabetes or diabetes mellitus type 2, patients of the Department of Exercise Medicine and Cardiovascular Rehabilitation at the University Hospital Olomouc, are randomized to receive either Vitadio or a conventional 6-month high-intensity lifestyle intervention program at the clinic. Vitadio is a mobile application delivering behavioral change program focused on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and one-on-one remote coaching. Personalization of the intervention is achieved by analyzing participant's interactions with the application. The conventional therapy consists of 5 face-to-face nutrition/lifestyle education sessions (at baseline, at 1st, 2nd and 3rd month, and at month 6). Participants in the control group can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator. In addition, all participants undergo a regular medical assessment at the clinic (baseline, month 3, month 6). The aim of the study is to assess feasibility and efficacy of digitally administered intervention by comparing evolution of weight, physical fitness, laboratory measures of metabolic health, blood pressure and other outcomes.

Interventions

DEVICEVitadio

A 6-month digitally administered behavioral change program Vitadio focus on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and remote coaching.

BEHAVIORALConventional high-intensity lifestyle intervention program

A 6-month high-intensity lifestyle intervention program consisting of 5 face-to-face nutrition/lifestyle education sessions. Participants can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator.

Sponsors

University Hospital Olomouc
CollaboratorOTHER
Vitadio s.r.o.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This prospective randomized controlled study evaluates efficacy of lifestyle intervention using digital application Vitadio as compared to conventional high-intensity lifestyle intervention program administered at a specialized clinic at a University hospital.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* obesity with body mass index (BMI) above 30 kg/m\^2 * insulin resistance or prediabetes or type 2 diabetes mellitus * acess to device with internet access (notebook, smartphone, tablet) * willingness and ability to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures

Exclusion criteria

* pregnancy * steroid treatment * type 2 diabetes mellitus on insulin therapy * severe renal and/or hepatic impairment * any impairments including mental and psychological or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study * inability to understand, consent to, or comply with the study protocol for any reason, including inability to read or comprehend Czech language * inability to comply with study procedures

Design outcomes

Primary

MeasureTime frameDescription
Change in body weightbaseline, three months, six monthscomparison of baseline and end program body weight

Secondary

MeasureTime frameDescription
change in adherence to lifestyle interventionbaseline, three months, six monthscomparison of baseline, three-month and end-program adherence to healthy lifestyle assigned both by subjective (adapted questionnaire) and objective (program usage frequency, attrition) measures between groups
change in waist circumferencebaseline, three months, six monthscomparison of baseline, three-month and end-program waist circumference between groups
change in body mass index (BMI)baseline, three months, six monthscomparison of baseline, three-month and end-program body mass index (BMI) between groups
change in haemoglobin A1cbaseline, three months, six monthscomparison of baseline, three-month and end-program haemoglobin A1c values between groups
change in blood glucosebaseline, three months, six monthscomparison of baseline, three-month and end-program blood glucose values between groups
change in insulin resistancebaseline, three months, six monthscomparison of baseline, three-month and end-program insulin resistance quantified by HOMA-IR between groups
change in body compositionbaseline, three months, six monthscomparison of baseline, three-month and end-program body composition assessed with the InBody bioelectrical impedance analysis device between groups
change in resting metabolic rate (RMR)baseline, three months, six monthscomparison of baseline, three-month and end-program resting metabolic rate assessed by indirect calorimetry between groups
change in cardiorespiratory fitnessbaseline, three months, six monthscomparison of baseline, three-month and end-program cardiorespiratory fitness assessed by spiroergometry between groups
change in lipid parameters (total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides)baseline, three months, six monthscomparison of baseline, three-month and end-program levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides between groups
change in fasting insulin levelsbaseline, three months, six monthscomparison of baseline, three-month and end-program fasting insulin levels between groups
change in liver function testsbaseline, three months, six monthscomparison of baseline, three-month and end-program standard liver panel (ALT, AST, GGT, ALP) values between groups
change in blood pressurebaseline, three months, six monthscomparison of baseline, three-month and end-program blood pressure between groups

Other

MeasureTime frameDescription
Vitadio usability for HCPssix monthsThe healthcare professionals' (HCPs) user experience from interacting with Vitadio Health, assessed with the User Experience Questionnaire (UEQ)

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026